- Book
- April 2019
- 836 Pages
Canada
- Report
- February 2019
- 55 Pages
Global
From €1050EUR$1,232USD£922GBP
- Training
- 120 Minutes
Global
- Training
- 60 Minutes
Global
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €457EUR$500USD£387GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €457EUR$500USD£387GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €457EUR$500USD£387GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €457EUR$500USD£387GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €457EUR$500USD£387GBP
From €3643EUR$3,990USD£3,092GBP
From €1913EUR$2,095USD£1,623GBP
€3643EUR$3,990USD£3,092GBP
From €1913EUR$2,095USD£1,623GBP
€3643EUR$3,990USD£3,092GBP
- Report
- May 2025
United States
From €1913EUR$2,095USD£1,623GBP
€3643EUR$3,990USD£3,092GBP
- Report
- May 2025
United Kingdom
From €1913EUR$2,095USD£1,623GBP
€3643EUR$3,990USD£3,092GBP
- Report
- May 2025
North America
From €1913EUR$2,095USD£1,623GBP
€3643EUR$3,990USD£3,092GBP
From €1913EUR$2,095USD£1,623GBP
€3643EUR$3,990USD£3,092GBP
- Report
- May 2025
Middle East
From €1913EUR$2,095USD£1,623GBP
€3643EUR$3,990USD£3,092GBP
- Report
- May 2025
Asia Pacific
From €1913EUR$2,095USD£1,623GBP
€3643EUR$3,990USD£3,092GBP
- Report
- January 2025
- 80 Pages
Global
From €3500EUR$4,106USD£3,075GBP

The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more